Familial Prostate Cancer
Watchlist
Retrieved
2021-01-23
Source
Trials
—
Genes
RNASEL,
HOXB13,
ELAC2,
MSR1,
CHEK2,
BRCA2,
BRCA1,
CDKN1B,
MSMB,
SRD5A2,
CDH1,
EPHB2,
NBN,
TTC28,
LARP4B,
KDM2A,
BCL2L11,
TSHZ1,
HAUS6,
DENND4B,
ADGRG1,
MBD2,
BCAS1,
PPFIBP2,
TCF7L2,
HNF1B,
TCF4,
B3GAT1,
MAD1L1,
UHRF1BP1
RNASEL,
HOXB13,
ELAC2,
MSR1,
CHEK2,
BRCA2,
BRCA1,
CDKN1B,
MSMB,
SRD5A2,
CDH1,
EPHB2,
NBN,
TTC28,
LARP4B,
KDM2A,
BCL2L11,
TSHZ1,
HAUS6,
DENND4B,
ADGRG1,
MBD2,
BCAS1,
PPFIBP2,
TCF7L2,
HNF1B,
TCF4,
B3GAT1,
MAD1L1,
UHRF1BP1,
COL23A1,
RN7SKP114,
RNU6-491P,
RNU6-148P,
THEG5,
MEIS1-AS3,
OACYLP,
DUBR,
RASSF3,
CDCA7,
RNF43,
MOB2,
ATAT1,
SUGCT,
RFX7,
PKNOX2,
FBRSL1,
KNL1,
RNLS,
EMSY,
RNU6-456P,
DOCK2,
PAX9,
MYO9B,
MMP14,
POU2F2,
MBNL1,
MAP2K1,
ITGB8,
INCENP,
CHD3,
HLA-DOA,
DNMT3B,
MECOM,
CASP8,
BCL2,
ATM,
ARHGAP6,
TOR1A,
KLK3,
PCAP,
CBX4,
HPCX,
AMACR,
KLF6,
AR,
HPC3,
CYP17A1,
MYC,
NPEPPS,
PROS1,
PSAT1,
PLAG1,
GSTK1,
CYP19A1,
RGS8,
BRIP1,
SLCO6A1,
MIR888,
ARL11,
CYP1B1,
CYP1A1,
RGSL1,
SULT1A1,
PALB2,
ERG,
RASA1,
PTEN,
TP53,
VDR,
SPOP,
PPM1D,
PPP2R2A,
PON1,
PKHD1,
LZTS1,
MLH1,
LGALS8,
KLK2,
RASA2,
PINX1,
GSTT1,
PDSS2,
GSTP1,
GSTM1,
CT55
Drugs
Registered!
Familial prostate cancer (FPC) is a malignant tumor of the prostate with an early onset. FPC is either asymptomatic or causes mictionary symptoms, erectile dysfunction, bone pain, venous compression and infectious or inflammatory syndrome (for the metastatic forms). It is also characterized by familial antecedents.